Literature DB >> 3292315

Induction of insulitis by adoptive transfer with L3T4+Lyt2- T-lymphocytes in T-lymphocyte-depleted NOD mice.

T Hanafusa1, S Sugihara, H Fujino-Kurihara, J Miyagawa, A Miyazaki, T Yoshioka, K Yamada, H Nakajima, H Asakawa, N Kono.   

Abstract

To clarify the pathogenesis of insulitis in the nonobese diabetic (NOD) mouse, an animal model for human insulin-dependent diabetes mellitus, T-lymphocyte-depleted NOD mice (B mice) were adoptively transferred with spleen and lymph node cells from cyclophosphamide-treated NOD mice after separating the cells with monoclonal antibodies against various T-lymphocyte surface antigens plus complement. Light-microscopic and immunohistochemical studies were also performed to investigate the lymphocytic infiltrations. The incidence of insulitis detected in B mice was much lower when compared with that of the lesion naturally occurring in the NOD mouse. However, higher incidence of insulitis was inducible in B mice by transferring unfractionated lymphoid cells from NOD mice. When the Thy1+ cell-depleted fraction was transferred into the B mice, no increase in the incidence of insulitis was observed. The Lyt1+ or L3T4+ cell-eliminated fraction was also unable to transfer insulitis. Conversely, donor cells depleted of Lyt2+ components successfully induced insulitis in the recipient B mice. These data were consistent with the immunohistochemical study, which showed that the main phenotype of the cells infiltrating the islets was L3T4+. These results suggest the importance of L3T4+Lyt2- T-lymphocytes in the pathogenesis of insulitis in NOD mice.

Entities:  

Mesh:

Year:  1988        PMID: 3292315     DOI: 10.2337/diab.37.2.204

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

Review 2.  The role of Fas-FasL in CD8+ T-cell-mediated insulin-dependent diabetes mellitus (IDDM).

Authors:  H T Kreuwel; L A Sherman
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

3.  Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.

Authors:  T Maki; T Ichikawa; R Blanco; J Porter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

4.  Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice.

Authors:  B Formby; N Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

5.  Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis.

Authors:  A Itoh; T Maki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.

Authors:  J M Johnson-Tardieu; E W Walworth; J G Cornelius; X Ye; S M Schuster; A B Peck
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  Accounting for chance in the calculus of autoimmune disease.

Authors:  Daniel J Moore
Journal:  Med Hypotheses       Date:  2009-10-01       Impact factor: 1.538

8.  Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.

Authors:  S Kitagawa; H Iwata; S Sato; J Shimizu; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

9.  Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence.

Authors:  M B Oldstone
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

10.  Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity.

Authors:  D Kägi; B Odermatt; P S Ohashi; R M Zinkernagel; H Hengartner
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.